Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion type Assertion NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_head.
- NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion description "[Taken together, our results suggest that miR-182 could be a valuable marker of glioma progression and that high miR-182 expression is associated with poor overall survival in patients with malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_provenance.
- NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion evidence source_evidence_literature NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_provenance.
- NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion SIO_000772 20472885 NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_provenance.
- NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion wasDerivedFrom befree-2016 NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_provenance.
- NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_assertion wasGeneratedBy ECO_0000203 NP812399.RAiRscchz0gLSKGNA1tmcNCxrCC9U_IojUoSJ1WgTrFgs130_provenance.